Author:
Bonin M,Pursche S,Bergeman T,Leopold T,Illmer T,Ehninger G,Schleyer E,Bornhauser M
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference19 articles.
1. Chun HG, Leyland-Jones BR, Caryk SM, Hoth DF . Central nervous system toxicity of fludarabine phosphate. Cancer Treat Rep 1986; 70: 1225–1228.
2. Gandhi V, Plunkett W . Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 2002; 41: 93–103.
3. Ross SR, McTavish D, Faulds D . Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy. Drugs 1993; 45: 737–759.
4. Gandhi V, Estey E, Du M, Keating MJ, Plunkett W . Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. Clin Cancer Res 1997; 3: 1539–1545.
5. Gandhi V, Robertson LE, Keating MJ, Plunkett W . Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology. Cancer Chemother Pharmacol 1994; 34: 30–36.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献